Dysregulation of HSG triggers vascular proliferative disorders
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Vascular proliferative disorders, such as atherosclerosis and restenosis, are the most common causes of severe cardiovascular diseases, but a common molecular mechanism remains elusive. Here, we identify and characterize a novel hyperplasia suppressor gene, named HSG (later re-named rat mitofusin-2). HSG expression was markedly reduced in hyper-proliferative vascular smooth muscle cells (VSMCs) from spontaneously hypertensive rat arteries, balloon-injured Wistar Kyoto rat arteries, or ApoE-knockout mouse atherosclerotic arteries. Overexpression of HSG overtly suppressed serum-evoked VSMC proliferation in culture, and blocked balloon injury induced neointimal VSMC proliferation and restenosis in rat carotid arteries. The HSG anti-proliferative effect was mediated by inhibition of ERK/MAPK signalling and subsequent cell-cycle arrest. Deletion of the p21(ras) signature motif, but not the mitochondrial targeting domain, abolished HSG-induced growth arrest, indicating that rHSG-induced anti-proliferation was independent of mitochondrial fusion. Thus, rHSG functions as a cell proliferation suppressor, whereas dysregulation of rHSG results in proliferative disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Besides its role in mitochondrial fusion, Mfn2 has been described to be involved in the regulation of cell proliferation, oxidative metabolism, autophagy, mitophagy, mitochondrial antiviral signaling, and unfolded protein response (Bach et al, 2003; Chen et al, 2004; Yasukawa et al, 2009; Hailey et al, 2010; Ngoh et al, 2012; Zhao et al, 2012; Chen & Dorn, 2013; Munoz et al, 2013).”
From Mfn2 deficiency links age‐related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway (2016) · cites this paper as Chen et al, 2004
In the citing paper
“Recently, it has been reported that Mfn2 binds Ras and its overexpression inhibits extracellular signalrelated kinase/mitogen-activated protein kinase signaling and subsequently arrests cell cycle (30).”
From Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle (2005) · cites this paper as [30]
Citations
Cites
Moses, J. W., Leon, M. B., Popma, J. J., Fitzgerald, P. J., Holmes, D. R., O'Shaughnessy, C., Caputo, R. P., Kereiakes, D. J., Williams, D. O., Teirstein, P. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035071 · Cited by 4,224 · cited 1×
“Recent studies indicate that coated stents with anti-proliferative agents, including rapamyci”
BackgroundMarshall, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90401-8 · Cited by 3,906 · cited 1×
“The Ras proto-oncogene is a central component of mitogenic signalling pathways, and is essential for cells to exit a quiescent state (G0) and to pass through the G1–S transition of the cell cycl”
BackgroundChen, H., Detmer, S. A., Ewald, A. J., Griffin, E. E., Fraser, S. E., & Chan, D. C. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200211046 · Cited by 2,601 · cited 1×
“Several studies have demonstrated that human Mfn-2 and its homologues localize to the mitochondrial outer membrane and have an essential role in mitochondrial fusion, thus regulating mitochondrial morphology and function in mammalian cells, yeast and flie”
BackgroundDevelopment of a Strain of Spontaneously Hypertensive Rats
OKAMOTO, K., & AOKI, K. (1963) · Japanese Circulation Journal · doi:10.1253/jcj.27.282 · Cited by 2,545
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., Loh, D. Y., & Nakayama, K.-I. (1996) · Cell · doi:10.1016/s0092-8674(00)81237-4 · Cited by 1,547
Fero, M. L., Rivkin, M., Tasch, M., Porter, P., Carow, C. E., Firpo, E., Polyak, K., Tsai, L.-H., Broudy, V., Perlmutter, R. M., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81239-8 · Cited by 1,457
Tunstall-Pedoe, H., Kuulasmaa, K., Mähönen, M., Tolonen, H., & Ruokokoski, E. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04021-0 · Cited by 1,444
Clowes, A. W., Reidy, M. A., & Clowes, M. M. (1983) · PubMed · Cited by 1,437
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome
Srivastava, S., Zou, Z., Pirollo, K., Blattner, W., & Chang, E. H. (1990) · Nature · doi:10.1038/348747a0 · Cited by 1,211 · cited 1×
“In fact, the anti-proliferative effect of human HSG is more potent than that induced by overexpression of p53, a well established tumour suppresso”
Background
Cited by
Items 301–368 of 368
Xu, X., Yao, Y.-M., Zhao, G., Wu, Z., Li, J.-C., Jiang, Y., Lu, Z., & Hong, G. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.223855 · Cited by 7
“MFN2 acts as a suppressor of proliferation and may inhibit the proliferation of vascular smooth muscle cells and MEFs.[3,37] Dasgupta et al.”
BackgroundWangJianju, W., Zhu, L., Zhang, J. W. J., & Zheng, L. (2012) · Cited by 6
Pro-apoptotic effects of rHSG on C6 glioma cells
Gao, P., Zou, Y., Zhang, B., Jiang, S., Hao, W., Guo, H., Huo, G., Wang, J., Zhao, W., & Shen, B. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2725 · Cited by 6
Yan, L., Luo, X., Hang, C., YuWang, Zhang, Z., Xu, S., & Du, L. (2024) · Respiratory Research · doi:10.1186/s12931-024-02957-1 · Cited by 6
“Interestingly, Mfn2 was initially identified as a “hyperplasia suppressor gene” due to its anti-proliferative function in vascular smooth muscle cells [17].”
BackgroundLu, Z., Tang, L., Zhao, G., Yao, Y.-M., Zhu, X.-M., Dong, N., & Yu, Y. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0054 · Cited by 5
Wang, Z., Liu, Y., Liu, J., Niu, Q., Wen, J., Wen, S., & Wu, Z. (2013) · Yonsei Medical Journal · doi:10.3349/ymj.2013.54.3.603 · Cited by 5
“603 pISSN: 0513-5796, eISSN: 1976-2437 Yonsei Med J 54(3):603-608, 2013”
Self-citationFan, R. (2011) · Journal of Chinese Integrative Medicine · doi:10.3736/jcim20110611 · Cited by 5
He, C., Chen, Y., Liu, C., Cao, M., Fan, Y.-J., & Guo, X. (2013) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-013-1099-6 · Cited by 5
Self-citationGoebel, J., Engelhardt, E., Pelzer, P., Sakthivelu, V., Jahn, H. M., Jevtic, M., Folz-Donahue, K., Kukat, C., Schauss, A., Frese, C. K., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/657999 · Cited by 6
Shu, Z., Zhang, X., Zheng, L., Zeng, G., Mo, Y., Yu, M., Zhang, X., & Tan, X. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27995 · Cited by 4
“Mfn‐2 is a protein that shows multiple functions, such as inhibiting proliferation in VSMC.15 Our data indicate the existence of a regulatory pathway that inhibits HASMC proliferation and is defined by PGC‐1α/ERR‐α/Mfn‐2.”
BackgroundEffects of Mitofusin2 on astrocytes proliferation in vitro induced by scratch injury
Shi, Y., Luo, P., Yi, C., Xie, J., & Zhang, Q. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.134969 · Cited by 4
Scorrano, L. (2009) · Springer eBooks · doi:10.1007/978-90-481-3415-1_13 · Cited by 5
Role of surface ectoderm-specific mitofusin 2 in the corneal morphologic development of mice.
Zhang, J., Qu, B., Yu, W., Zhu, Y., Yan, X., Shen, H., & Zhao, J. (2019) · Europe PMC (PubMed Central) · Cited by 5
Filadi, R., Zampese, E., Pozzan, T., Pizzo, P., & Fasolato, C. (2012) · Springer eBooks · doi:10.1007/978-94-007-4351-9_4 · Cited by 7
Liao, Z., & He, Y. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1623775 · Cited by 5
Rothwell, S., Ng, I., Shalchy-Tabrizi, S., Kalinowski, P., Taha, O., Paris, I., Baniqued, A., Lin, L., Mezei, M. M., Lehman, A., et al. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2024.1488248 · Cited by 4
Li, J., Xu, M., Dai, Z., & Xu, T. (2020) · Current Medical Science · doi:10.1007/s11596-020-2305-y · Cited by 3
Mitochondrial Bioenergetics and Dynamics During Infection
Soultawi, C., Fortier, Y., Soundaramourty, C., Estaquier, J., & Laforge, M. (2018) · Experientia supplementum · doi:10.1007/978-3-319-74932-7_5 · Cited by 4
p55γ functional mimetic peptide N24 blocks vascular proliferative disorders
Guo, J., Xie, N., Li, G., Zhang, Y., Lv, F., Guo, S., Feng, Y., Cao, C.-M., & Xiao, R.-P. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1287-x · Cited by 4
“As described previously [19, 21], rat carotid arteries were subjected to balloon injury, then infected with adenovirus (Ad-GFP or Ad-N24 at 1×10(9) pfu) and the neointimal formation was assessed 14 days later.”
MethodSelf-citationSuppression of C6 Gliomas via Application of Rat Hyperplasia Gene
Gao, P., Wang, Z., Zhang, B., Zou, Y., Guo, H., Liu, H., Yang, Q., Fang, Z., Jiang, S., Shen, B., et al. (2014) · The International Journal of Biological Markers · doi:10.5301/jbm.5000114 · Cited by 3
“Moreover, the functions of pAdxsi are limited and have high affinity to receptors on the glioma cell surface, so as to avoid damage of surrounding brain tissues (20).”
BackgroundChatterjee, S., Hossain, U., & Sil, P. C. (2019) · Springer eBooks · doi:10.1007/978-981-13-8946-7_19 · Cited by 3
Roles of Macrophage Mitochondrial Oxidative Stress and Mitochondrial Fission in Atherosclerosis
Wang, Y. (2014) · doi:10.7916/d84x55xn · Cited by 3
Yuan, X., Hou, M., Wang, Y., Zhang, S., Li, L., Mi, Y.-J., Du, H., Yu, S., & Nan, Y. (2023) · Journal of International Medical Research · doi:10.1177/03000605231187953 · Cited by 2
6.2 Mitochondrial-Endoplasmic Reticulum Interactions
Szabadkai, G., & Rizzuto, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-30411-3_23 · Cited by 2
OCIAD2 Promotes Cancer Progression via Metabolic Reprogramming in Lung Adenocarcinoma
Huang, Y.-H., Chang, W., Shen, C.-Y., Su, K., Chang, G., Chen, J., Lee, W.-Y., Chen, Y., & Yu, S. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00273 · Cited by 2
Research progress on cellular behavior of CaSR in cardiovascular diseases
liu, X., Xie, T., Qadir, J., Li, S., Xu, T., Lu, Y., Ge, X., & Yuan, H. S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1672536 · Cited by 1
“In addition, studies have shown that the inhibition of extracellular signal-regulated kinase/ mitogen-activated protein kinase (ERK/MAPK) mediated by MFN2 leads to cell cycle arrest (111 – 113).”
An, W., Reyes, C., Espinosa‐Díez, C., Patel, P., Guimaraes, D., Villareal, F., Jessup, M., Croix, C. S., Gomez, D. A., Rao, K., et al. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104169 · Cited by 1
“Our in vivo data bridge several pre-clinical studies that demonstrate that nitrite [35 – 37] or inhibition of mitochondrial fission [20,26,51,53] independently attenuate intimal hyperplasia.”
Cytoskeleton, Axonal Transport, and the Mechanisms of Axonal Neuropathy
Cheng, H. T., Callaghan, B. C., Dauch, J. R., & Feldman, E. L. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-6787-9_27 · Cited by 3
“growth factor (NGF) binds to the cell membrane high affinity Trk A receptor in the axonal terminals ( Chao, 2003 ).”
BackgroundYan, S., Lian, X., Wang, S., Wang, H., & Wang, L. (2020) · PubMed · Cited by 2
OPA 1 and Its Clinical Implications
Trevisson, E., Salviati, L., & Scorrano, L. (2009) · Wiley eBooks · doi:10.1002/9780470015902.a0021785 · Cited by 1
The effects of Med12 variation upon cell cycle progression and differential gene expression
Wernett, P. J. (2011) · doi:10.17077/etd.u9bwzmgx
“Inhibition of these signaling cascades could result in cell cycle arrest [105, 106].”
BackgroundAlmontashiri, N. A. M. (2012) · uO Research (University of Ottawa) · doi:10.20381/ruor-2917
Regulating a uniter: control of mitofusin 2 expression
Knowlton, A. A., & Chen, L. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs101
Advanced renal disease: Safe and effective benazepril
Fox, J. (2007) · Nature China · doi:10.1038/nchina.2007.070118-6
Dissecting Neurofibromatosis Type 1 Related Vasculopathy
Lasater, E. A. (2010) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1788
Hu, J.-W., Yan, J., Ya-qi, W., Jing-hua, Z., Lei, W., Li, Y., Liu, Y., Ma, J., Ning, L., Shunli, Z., et al. (2015) · Journal of Cancer Prevention · doi:10.12691/ajcp-3-6-3
“Studies of vascular proliferative disorders have demonstrated that the overexpression of HSG markedly suppressed serumevoked vascular smooth muscle cell (VSMC) proliferation in culture and blocked balloon injury-induced neointimal VSMC proliferation and restenosis in rat carotid arteries [6].”
BackgroundRamió‐Lluch, L., & Rodríguez-Gil, J. E. (2009) · TDX (Tesis Doctorals en Xarxa)
Regulation of vascular smooth muscle cell phenotype.
Salabei, J. K. (2012) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/1250
“However, the role of mitochondria in the VSMC during phenotype conversion has not been given great attention with only a few recent studies suggesting a role of Mfn2, Drp1 and mitochondria morphology in VSMC hyperproliferation under diseased conditions [244-245].”
BackgroundResultGuillet, V., & REYNIER, P. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 2
de Araújo, G. W., & Beyer, C. (2012)
Vascular Stenosis: Hemodynamics and Drug Elution
Thiriet, M., Delfour, M. C., & Garon, A. (2014) · Springer eBooks · doi:10.1007/978-3-642-37393-0_32-1 · Cited by 2
The Evolving Concept of Mitochondrial Dynamics in Heart: Interventional Opportunities
Ashok, S., Ganjoo, M., Panicker, V. T., Pillai, V. V., & Gopala, S. (2019) · Springer eBooks · doi:10.1007/978-981-13-8946-7_25
Wang, J., Zhang, B., Liu, H., Wu, Q., Gao, P., Zou, Y., Lan, Y., & Zhang, Q. (2020) · PubMed Central
Anti-tumour efficacy of mitofusin-2 in urinary bladder carcinoma
JinGuanghou, B., Pan, F., ChengLin, X., Lv, Z., & Zheng, G. C. (2011)
Bergamin, G. (2011) · Padua Research Archive (University of Padova)
Zhang, X., Xu, X., Lu, L., Wan, X., Qin, Y., Ruan, W., Lv, C., He, L., & Guo, X. (2021) · Figshare · doi:10.6084/m9.figshare.16641849
Self-citationZhao, J.-Z., Li, Q.-Y., Lin, J.-J., Yang, L.-Y., Du, M.-Y., Wang, Y., Liu, K.-X., Jiang, Z., Li, H.-H., Wang, S.-F., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20080928
Self-citationZhao, J.-Z., Li, Q.-Y., Lin, J.-J., Yang, L.-Y., Du, M.-Y., Wang, Y., Liu, K.-X., Jiang, Z.-A., Li, H.-H., Wang, S.-F., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20080949
Self-citationZhao, J.-Z., Li, Q.-Y., Lin, J.-J., Yang, L.-Y., Du, M.-Y., Wang, Y., Liu, K.-X., Jiang, Z.-A., Li, H.-H., Wang, S.-F., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20080940
Self-citationZhao, J.-Z., Li, Q.-Y., Lin, J.-J., Yang, L.-Y., Du, M.-Y., Wang, Y., Liu, K.-X., Jiang, Z.-A., Li, H.-H., Wang, S.-F., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20080943
Self-citationZhao, J.-Z., Li, Q.-Y., Lin, J.-J., Yang, L.-Y., Du, M.-Y., Wang, Y., Liu, K.-X., Jiang, Z.-A., Li, H.-H., Wang, S.-F., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20080952
Self-citationZhao, J.-Z., Li, Q.-Y., Lin, J.-J., Yang, L.-Y., Du, M.-Y., Wang, Y., Liu, K.-X., Jiang, Z.-A., Li, H.-H., Wang, S.-F., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20080961
Self-citationZhao, J.-Z., Li, Q.-Y., Lin, J.-J., Yang, L.-Y., Du, M.-Y., Wang, Y., Liu, K.-X., Jiang, Z.-A., Li, H.-H., Wang, S.-F., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20080925
Self-citationZhao, J.-Z., Li, Q.-Y., Lin, J.-J., Yang, L.-Y., Du, M.-Y., Wang, Y., Liu, K.-X., Jiang, Z.-A., Li, H.-H., Wang, S.-F., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20080931
Self-citationZhao, J.-Z., Li, Q.-Y., Lin, J.-J., Yang, L.-Y., Du, M.-Y., Wang, Y., Liu, K.-X., Jiang, Z.-A., Li, H.-H., Wang, S.-F., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20080919
Self-citationZhao, J.-Z., Li, Q.-Y., Lin, J.-J., Yang, L.-Y., Du, M.-Y., Wang, Y., Liu, K.-X., Jiang, Z.-A., Li, H.-H., Wang, S.-F., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20080958
Self-citationZhao, J.-Z., Li, Q.-Y., Lin, J.-J., Yang, L.-Y., Du, M.-Y., Wang, Y., Liu, K.-X., Jiang, Z.-A., Li, H.-H., Wang, S.-F., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20080922
Self-citationZhao, J.-Z., Li, Q.-Y., Lin, J.-J., Yang, L.-Y., Du, M.-Y., Wang, Y., Liu, K.-X., Jiang, Z.-A., Li, H.-H., Wang, S.-F., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20080946
Self-citationZhao, J.-Z., Li, Q.-Y., Lin, J.-J., Yang, L.-Y., Du, M.-Y., Wang, Y., Liu, K.-X., Jiang, Z.-A., Li, H.-H., Wang, S.-F., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20080916
Self-citationSubcellular Stress Markers in Epithelial Ovarian Cancer
Wappler-Guzzetta, E. A., Margittai, É., Veszelyi, K., Pickard, S. C., Merwin, C., Molvarec, A., & Czegle, I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010342
“Although Mfn1 and Mfn2 are structurally similar GTPases, Mfn2 has a Ras-binding domain [55], and often inhibits Ras downstream signaling via sequestration [56].”
Research Progress on the Mechanism of Mfn2 in Vascular Intimal Hyperplasia of Arteriovenous Fistula
张, 晟. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.162509
Nguyen, P. M. C. (2015) · theses.fr (ABES) · doi:10.70675/f5d28b69zead0z45d6z8d1cz92ab36aab66c
Rôle de la Thrombospondine-1 dans le remodelage vasculaire
Grenier, C. (2016) · theses.fr (ABES) · doi:10.70675/32ae12b8z1945z4c94z8696z4bfe4e8cc8ee
Modèles cellulaires pour l'étude des mécanismes sous jacents aux maladies neuromusculaires rares
Puma, A. R. (2023) · theses.fr (ABES) · doi:10.70675/b50d3134z80fbz4d0dz8b6ez61a950ee0307
LncRNA H19 promotes vascular remodeling by inhibiting MFN2
Yang, S., Meng, L., Wang, S.-F., Xie, Y.-Q., Yang, L.-Y., Wang, S., Wang, Z.-Y., Li, X.-Z., Li, Y.-M., Xu, X., et al. (2026) · Functional & Integrative Genomics · doi:10.1007/s10142-026-02043-3
“In addition, the inhibitory effects of MFN2 on vascular remodeling can be fulfilled by suppressing the ERK1/2 signaling (Chen et al. 2004; Feng et al. 2019).”
Influential
Metadata
- Authors
- Chen, K.-H., Guo, X., Ma, D., Guo, Y., Li, Q., Yang, D., Li, P., Qiu, X., Wen, S., Xiao, R.-P., & Tang, J.
- Affiliations
- National Institutes of Health (US)
- Peking University (CN)
- Corresponding author
- Xiao, Rui-Ping
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2004-08-22
- Volume
- 6
- Issue
- 9
- Pages
- 872-883
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2104828119
- Cited by
- 370
- References
- 50
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 6 · 2023: 12 · 2022: 26 · 2021: 22 · 2020: 18 · 2019: 19 · 2018: 22 · 2017: 18 · 2016: 21 · 2015: 24 · 2014: 20 · 2013: 32 · 2012: 26
- FWCI
- 4.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Surgery › Cardiovascular, Neuropeptides, and Oxidative Stress Research
- Keywords
- HSG, mitofusin 2, vascular smooth muscle cell proliferation, restenosis, intimal hyperplasia, atherosclerosis, ERK/MAPK signalling, cell cycle arrest, mitochondrial targeting, mitochondrial fusion, spontaneously hypertensive rats, balloon injury, ApoE-deficient mice
- MeSH terms
- Animals, Arteriosclerosis, Cardiovascular Diseases, Cell Division, Gene Expression Regulation, Humans, Membrane Proteins, Molecular Sequence Data, Muscle, Smooth, Vascular, Oncogene Protein p21(ras), Mice, Knockout, GTP Phosphohydrolases, MAP Kinase Signaling System, Coronary Restenosis, Mitochondrial Proteins, Myocytes, Smooth Muscle, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.